FDA Inspection 562710 — Nephron Pharmaceuticals
The FDA completed an inspection of Nephron Pharmaceuticals on Nov 4, 2008 in Mountain Home, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 4, 2008
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mountain Home, ID (United States)